These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8721283)

  • 21. Development of a quantitative vancomycin immunoassay for the Abbott AxSYM analyzer.
    Adamczyk M; Brate EM; Chiappetta EG; Ginsburg S; Hoffman E; Klein C; Perkowitz MM; Rege SD; Chou PP; Costantino AG
    Ther Drug Monit; 1998 Apr; 20(2):191-201. PubMed ID: 9558134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of haptens by homogeneous immunoprecipitation. 2. Centrifugal analysis for tobramycin, phenobarbital, and theophylline in serum.
    Wu JW; Bunyagidj C; Hoskin S; Riebe SM; Aucker J; White K; O'Neill SP
    Clin Chem; 1983 Aug; 29(8):1540-2. PubMed ID: 6347431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Assays to Measure Aminoglycosides in Serum: Comparison of Accuracy and Precision Based on External Quality Assessment.
    Li M; Ma L; Chen C; Lei L; Zhai X; Luo D; Zhou Y; Cui Y
    Ther Drug Monit; 2020 Oct; 42(5):710-715. PubMed ID: 32118804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of an immunoassay and a microbiological assay for tobramycin serum concentrations.
    Fukuchi H; Yoshida M; Okihara M; Tokuoka S; Konishi T
    Am J Hosp Pharm; 1981 Dec; 38(12):1933-6. PubMed ID: 6798863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitation of serum tobramycin concentration using high-pressure liquid chromatography.
    Maitra SK; Yoshikawa TT; Hansen JL; Schotz MC; Guze LB
    Am J Clin Pathol; 1979 Apr; 71(4):428-32. PubMed ID: 443201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of four assay methods for determination of tobramycin in human serum.
    Acton WJ; Van Duyn OM; Allen LV; Flournoy DJ
    Clin Chem; 1982 Jan; 28(1):177-80. PubMed ID: 7035000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of in vitro inactivation of tobramycin by imipenem/cilastatin.
    Ariano RE; Kassum DA; Meatherall RC; Patrick WD
    Ann Pharmacother; 1992 Sep; 26(9):1075-7. PubMed ID: 1421667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of various storage conditions on a fluorescence polarization immunoassay for tobramycin.
    Cohen IA; DeKeyser JM; Hyder DM
    Am J Hosp Pharm; 1985 Mar; 42(3):605-9. PubMed ID: 3985025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum aminoglycoside monitoring by enzyme immunoassay, biological, and fluorescence immunoassay procedures.
    Buchanan AG; Witwicki E; Albritton WL
    Am J Med Technol; 1983 Jun; 49(6):437-41. PubMed ID: 6349357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abbott AxSYM Vancomycin II assay: multicenter evaluation and interference studies.
    Azzazy HM; Chou PP; Tsushima JH; Troxil S; Gordon M; Avers RJ; Chiappetta E; Duh SH; Christenson RH
    Ther Drug Monit; 1998 Apr; 20(2):202-8. PubMed ID: 9558135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interpretations of the TDxFLx calibration data of the abused drugs.
    Sihn YS; Chung HS
    Forensic Sci Int; 2003 Jan; 131(1):1-7. PubMed ID: 12505464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of tobramycin in bronchoalveolar lavage fluid by a modified fluorescence polarization immunoassay.
    Govantes C; Carcas AJ; Garcia-Stue JL; Zapater P; Frias J
    J Antimicrob Chemother; 1995 Dec; 36(6):1111-3. PubMed ID: 8821620
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis.
    Bates RD; Nahata MC; Jones JW; McCoy K; Young G; Cox S; Barson WJ
    Chest; 1997 Nov; 112(5):1208-13. PubMed ID: 9367459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analytical accuracy of determinations of aminoglycoside concentrations by enzyme multiplied immunoassay, fluorescence polarization immunoassay, and radioimmunoassay in the presence of heparin.
    O'Connell ME; Heim KL; Halstenson CE; Matzke GR
    J Clin Microbiol; 1984 Dec; 20(6):1080-2. PubMed ID: 6394612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assay of gentamicin and tobramycin in sera of patients by gas-liquid chromatography.
    Mayhew JW; Gorbach SL
    Antimicrob Agents Chemother; 1978 Dec; 14(6):851-55. PubMed ID: 369455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aminoglycoside forecasting in neutropenic patients with cancer.
    Kosirog JL; Rospond RM; Destache C; Hall P
    Clin Pharmacokinet; 1993 Jan; 24(1):79-87. PubMed ID: 8448975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum gentamicin, netilmicin and tobramycin assays by high performance liquid chromatography.
    Marples J; Oates MD
    J Antimicrob Chemother; 1982 Oct; 10(4):311-8. PubMed ID: 7142078
    [No Abstract]   [Full Text] [Related]  

  • 38. Particle concentration fluorescence immunoassay of gentamicin.
    Varma-Nelson P; Nelson JE; Belknap SM
    Ther Drug Monit; 1991 May; 13(3):260-2. PubMed ID: 1926282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A fluorescence polarization immunoassay evaluated for quantifying astromicin, a new aminoglycoside antibiotic.
    Uematsu T; Sato R; Mizuno A; Nishimoto M; Nagashima S; Nakashima M
    Clin Chem; 1988 Sep; 34(9):1880-2. PubMed ID: 3416438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition of instilled versus nebulized tobramycin and imipenem in ventilated intensive care unit (ICU) patients.
    Badia JR; Soy D; Adrover M; Ferrer M; Sarasa M; Alarcón A; Codina C; Torres A
    J Antimicrob Chemother; 2004 Aug; 54(2):508-14. PubMed ID: 15215224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.